Alaunos Therapeutics, Inc. (TCRT): R&D Expense
$1.36M
Year ended 2025-12-31
$1.65M
Trailing 12 months to 2026-06-30
-62.1%
3-year compound annual growth
-51.9%
5-year compound annual growth
-35.3%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.36M | +276.5% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $362.0K | -97.8% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $16.28M | -34.9% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $25.02M | -49.6% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $49.64M | -5.8% | 2023-03-07, From 2021-01-01 |
| 2020-12-31 | $52.70M | +37.5% | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $38.33M | +12.3% | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | $34.13M | -24.3% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $45.08M | -71.4% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $157.79M | +47.8% | 2019-03-05, From 2016-01-01 |
| 2015-12-31 | $106.78M | +226.5% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $32.71M | -23.7% | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $42.85M | -48.6% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $83.45M | +46.2% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $57.08M | +342.2% | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | $12.91M | +183.4% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $4.56M | n/a | 2012-02-29, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $1.36M | +276.5% |
| Aspire Biopharma Holdings, Inc. (ASBP) | 2025-12-31 | $923.9K | +540.0% |
| Aditxt, Inc. (ADTX) | 2025-12-31 | $3.19M | -70.7% |
| Genelux Corp (GNLX) | 2025-12-31 | $19.85M | +4.5% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $1.14M | -90.3% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $2.09M | +323.5% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $6.03M | -10.2% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $340.0K | +22.3% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $158.68M | -7.5% |
Compare TCRT, ASBP, ADTX, GNLX side by side · Screen every company in Pharmaceutical Preparations ↗